Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients

Transplant International

Volumn 15, Issue 11, 2002, Pages 550-555

  Grimbert, Philippe ^a   Baron, Christophe ^a   Fruchaud, Ghislaine ^a   Hemery, François ^a   Desvaux, Dominique ^a   Buisson, Claude ^a   Chopin, Dominique ^a   Dahmane, Djamel ^a   Remy, Philippe ^a   Pastural, Myriam ^a   Abbou, Claude ^a   Weil, Bertrand ^a   Lang, Philippe ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Anti lymphocyte globulin; Cyclosporine; Graft survival; Long term outcome; Renal transplantation

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CREATININE; CYCLOSPORIN A; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; OKT 3; PREDNISONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG MEGADOSE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

ADULT; ANTILYMPHOCYTE SERUM; AZATHIOPRINE; CREATININE; CYCLOSPORINE; DRUG COMBINATIONS; FEMALE; GLUCOCORTICOIDS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDNISONE; RETREATMENT; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036937862     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2002.tb00106.x     Document Type: Article

References (35)

1. Anonymous (1983) Cyclosporin in cadaveric renal transplantation: 1-year follow-up of a multicentre trial. Lancet 2:986-989
2. Anonymous (1986) Canadian Multicentre Transplant Study Group. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at 3 years. The Canadian Multicentre Transplant Study Group. N Engl J Med 314:1219-1225
3. Bia MJ (1995) Nonimmunologic causes of late renal graft loss. Kidney Int 47:1470-1480
4. Carpenter CB (1995) Long-term failure of renal transplants: adding insult to injury. Kidney Int [Suppl] 50:40-44
5. Dantal J, Hourmant M, Cantarovich D, Giral M, Blancho G, Dreno B, Soulillou JP (1998) Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 351:623-628
6. Delmonico FL, Tolkoff-Rubin N, Auchincloss HJ, Williams WWJ, Fang LT, Bazari H, Farrell ML, Cosimi AB (1994) Management of the renal allograft recipient: immunosuppressive protocols for long-term success. Clin Transplant 8:34-39
7. Dubey D, Kumar A, Srivastava A, Mandhani A, Sharma AP, Gupta A, Sharma RK (2001) Cyclosporin A withdrawal in live related renal transplantation: long-term results. Clin Transplant 15:136-141
8. Ghoneim MA, Sobh MA, Shokeir AA, Bakr MA, el-Sherif AK, Fouda MA (1993) Prospective randomized study of azathioprine versus cyclosporin in livedonor kidney transplantation. Am J Nephrol 13:437-441
9. Gjertson DW, Terasaki PI (1992) The large center variation in half-lives of kidney transplants. Transplantation 53:357-362
10. Gonwa TA, Nghiem DD, Schulak JA, Corry RJ (1987) Results of conversion from cyclosporine to azathioprine in cadaveric renal transplantation. Transplantation 43:225-228
11. Grinyo JM, Gil-Vernet S, Seron D, Hueso M, Fulladosa X, Cruzado JM, Moreso F, Fernandez A, Torras J, Riera L, Castelao AM, Alsina J (1998) Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft. Nephrol Dial Transplant 13:2601-2604
12. Groth CG, Backman L, Morales JM, Calne R, Kreis H, Lang P, Touraine JL, Claesson K, Campistol JM, Durand D, Wramner L, Brattstrom C, Charpentier B (1999) Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. Transplantation 67:1036-1042
13. Hall BM, Tiller DJ, Hardie I, Mahony J, Mathew T, Thatcher G, Miach P, Thomson N, Sheil AG (1988) Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine. N Engl J Med 318:1499-1507
14. Halloran PF (2000) Immunosuppression in the post-adaptation period. Transplantation 70:3-5
15. Heim-Duthoy KL, Chitwood KK, Tortorice KL, Massy ZA, Kasiske BL (1994) Elective cyclosporine withdrawal 1 year after renal transplantation. Am J Kidney Dis 24:846-853
16. Hoitsma AJ, Wetzels JF, van Lier HJ, Berden JH, Koene RA (1987) Cyclosporin treatment with conversion after 3 months versus conventional immunosuppression in renal allograft recipients. Lancet 1:584-586
17. Hollander AA, van Saase JL, Kootte AM, van Dorp WT, van Bockel HJ, van Es LA, van der Woude FJ (1995) Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation. Lancet 345:610-614
18. Johnson CP, Simmons RL, Sutherland DE, Canafax DM, Ascher NL, Payne WD, Flick B, Najarian JS, Fryd DS (1988) A randomized trial comparing cyclosporine with antilymphoblastglobulin-azathioprine for renal allograft recipients, Results at 2 1/2-6 years. Transplantation 45:380-385
19. Kahn D, Ovnat A, Pontin AR, Swanepoel CR, Cassidy MJ (1994) Long-term results with elective cyclosporine withdrawal at 3 months after renal transplantation-appropriate for livingrelated transplants. Transplantation 58:1410-1412
20. Kasiske BL, Heim-Duthoy K, Ma JZ (1993) Elective cyclosporine withdrawal after renal transplantation. A metaanalysis. JAMA 269:395-400
21. Kasiske BL, Chakkera HA, Louis TA, Ma JZ (2000) A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 11:1910-1917
22. Kootte AM, Lensen LM, van Es LA, Paul LC (1988) Controlled cyclosporine conversion at 3 months after renal transplantation. Long-term results. Transplantation 46:677-680
23. Kreis H, Cisterne JM, Land W, Wramner L, Squifflet JP, Abramowicz D, Campistol JM, Morales JM, Grinyo JM, Mourad G, Berthoux FC, Brattstrom C, Lebranchu Y, Vialtel P (2000) Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation 69:1252-1260
24. MacPhee IA, Bradley JA, Briggs JD, Junor BJ, MacPherson SG, McMillan MA, Rodger RS, Watson MA (1998) Long-term outcome of a prospective randomized trial of conversion from cyclosporine to azathioprine treatment 1 year after renal transplantation. Transplantation 66:1186-1192
25. Marcen R, Pascual J, Teruel JL, Villafruela JJ, Rivera ME, Mampaso F, Burgos FJ, Ortuno J (2001) Outcome of cadaveric renal transplant patients treated for 10 years with cyclosporine: is chronic allograft nephropathy the major cause of late graft loss? Transplantation 72:57-62
26. Merion RM, White DJ, Thiru S, Evans DB, Calne RY (1984) Cyclosporine: five years' experience in cadaveric renal transplantation. N Engl J Med 310:148-154
27. Morris PJ, Chapman JR, Allen RD, Ting A, Thompson JF, Dunnill MS, Wood RF (1987) Cyclosporin conversion versus conventional immunosuppression: long-term follow-up and histological evaluation. Lancet 1:586-591
28. Ponticelli C, Civati G, Tarantino A, Quarto DP, Corbetta G, Minetti L, Vegeto A, Belli L (1996) Randomized study with cyclosporine in kidney transplantation: 10-year follow-up. J Am Soc Nephrol 7:792-797
29. Rocher LL, Milford EL, Kirkman RL, Carpenter CB, Strom TB, Tilney NL (1984) Conversion from cyclosporine to azathioprine in renal allograft recipients. Transplantation 38:669-674
30. Sevaux RG, Gregoor PJ, Hene RJ, Hoitsma AJ, Vos P, Weimar W, Gelder TV, Hilbrands LB (2001) A controlled trial comparing two doses of cyclosporine in conjunction with mycophenolate mofetil and corticosteroids. J Am Soc Nephrol 12:1750-1757
31. Shen SY, Weir MR, Coughlin TR (1989) Renal allograft biopsy and conversion of cyclosporine to azathioprine. Transplantation 47:223-229
32. Smak GP, van Gelder T, van Besouw NM, van der Mast BJ, IJzermans JN, Weimar W (2000) Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction. Transplantation 70:143-148
33. Solez K, Vincenti F, Filo RS (1998) Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. Transplantation 66:1736-1740
34. Szczech LA, Berlin JA, Aradhye S, Grossman RA, Feldman HI (1997) Effect of anti-lymphocyte induction therapy on renal allograft survival: a meta-analysis. J Am Soc Nephrol 8:1771-1777
35. Takiff HM, Ray M, Terasaki PI (1986) Factors important in 10-year kidney transplant survival. In: UCLA tissue typing laboratory, clinical transplants edn. Los Angeles, pp 157-163